Tata Steel’s shares dipped despite a 147% surge in Q4 FY26 net profit to Rs 2,965 crore. Analysts are divided, with JPMorgan downgrading to ‘Neutral’ citing regulatory headwinds in the Netherlands and project delays, while Morgan Stanley maintains ‘Overweight’ on strong domestic and UK performance.
Pharma seen as safe bet amid currency volatility, says Ambareesh Baliga
Market veteran Ambareesh Baliga suggests pharmaceutical stocks offer a safe haven amidst currency volatility and cautious foreign investor sentiment. He advises focusing on top-tier pharma